MedPath
NMPA Approval

复方肝炎颗粒

国药准字Z52020017

June 3, 2019

Drug Information

复方肝炎颗粒

颗粒剂

每袋装14g(相当于原药材22g)

中药

June 3, 2019

Company Information

Applicant Company

Manufacturing Company

贵州省贵阳市乌当区高新北路5号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方肝炎颗粒 - NMPA 批准文号 | MedPath